Winchester Group’s Merck MRK Stock Holding History

Winchester Group’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q3	$5.88M	Sell	129,411 -388	-0.3%	-$17.7K	1.29%	10
2013 Q2	$5.75M	Buy	+129,799	New	+$5.8M	1.23%	10

Other funds holding MRK

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Winchester Group's MRK Position: Q3 2013 in Review

Winchester Group reduced its Merck (MRK) stake by 0.3% in Q3 2013, selling an estimated $17.7K and leaving 129,411 shares worth $5.88M. The position accounts for 1.29% of the portfolio, ranked #10.

Winchester Group first reported a position in MRK in Q2 2013 and has held it in 2 quarters since. 1,470 funds tracked by Wall St. Rank hold MRK as of Q3 2013.

Winchester Group held 129,411 shares of Merck worth $5.88M as of Q3 2013.
Winchester Group sold 388 Merck shares in Q3 2013, an estimated $17.7K.
Merck made up 1.29% of Winchester Group's portfolio in Q3 2013, its #10 holding.
Winchester Group first reported a position in Merck in Q2 2013 and has held it in 2 quarters since.
1,470 funds tracked by Wall St. Rank held Merck as of Q3 2013.

Based on Winchester Group's 13F filing for Q3 2013, filed 16 Oct 2013.